Eisaku Ogawa

1.8k total citations · 1 hit paper
31 papers, 1.3k citations indexed

About

Eisaku Ogawa is a scholar working on Molecular Biology, Immunology and Rheumatology. According to data from OpenAlex, Eisaku Ogawa has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Immunology and 8 papers in Rheumatology. Recurrent topics in Eisaku Ogawa's work include Psoriasis: Treatment and Pathogenesis (7 papers), Cancer-related Molecular Pathways (4 papers) and Dermatology and Skin Diseases (4 papers). Eisaku Ogawa is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (7 papers), Cancer-related Molecular Pathways (4 papers) and Dermatology and Skin Diseases (4 papers). Eisaku Ogawa collaborates with scholars based in Japan, United States and Switzerland. Eisaku Ogawa's co-authors include Ryuhei Okuyama, Yuki Sato, Akane Minagawa, Setsuya Aiba, Hachiro Tagami, Shuntaro Ikawa, Taku Fujimura, Keiko Nakayama, Eri Kobayashi and Ryo Funayama and has published in prestigious journals such as Journal of Biological Chemistry, Nature Immunology and Oncogene.

In The Last Decade

Eisaku Ogawa

30 papers receiving 1.2k citations

Hit Papers

Pathogenesis of psoriasis... 2017 2026 2020 2023 2017 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eisaku Ogawa Japan 16 501 479 415 186 130 31 1.3k
Thomas Rosenbach Germany 21 403 0.8× 372 0.8× 372 0.9× 61 0.3× 120 0.9× 44 1.1k
Hongwei Han China 23 553 1.1× 690 1.4× 384 0.9× 160 0.9× 367 2.8× 63 2.0k
Thirunavukkarasu Velusamy United States 18 480 1.0× 254 0.5× 147 0.4× 230 1.2× 72 0.6× 38 1.3k
Jianxin Gao China 18 306 0.6× 253 0.5× 94 0.2× 117 0.6× 61 0.5× 34 961
Mingliang Chen China 19 381 0.8× 203 0.4× 143 0.3× 116 0.6× 117 0.9× 56 983
Duen-Yi Huang Taiwan 20 565 1.1× 344 0.7× 60 0.1× 170 0.9× 113 0.9× 41 1.1k
Yo Kawakubo Japan 15 126 0.3× 227 0.5× 276 0.7× 43 0.2× 95 0.7× 33 703
Ana Silva Portugal 17 557 1.1× 334 0.7× 73 0.2× 164 0.9× 73 0.6× 45 1.2k
Motohiro Kurosawa Japan 21 321 0.6× 604 1.3× 128 0.3× 62 0.3× 473 3.6× 127 1.4k
Yoko Funasaka Japan 15 229 0.5× 199 0.4× 353 0.9× 134 0.7× 35 0.3× 54 967

Countries citing papers authored by Eisaku Ogawa

Since Specialization
Citations

This map shows the geographic impact of Eisaku Ogawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eisaku Ogawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eisaku Ogawa more than expected).

Fields of papers citing papers by Eisaku Ogawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eisaku Ogawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eisaku Ogawa. The network helps show where Eisaku Ogawa may publish in the future.

Co-authorship network of co-authors of Eisaku Ogawa

This figure shows the co-authorship network connecting the top 25 collaborators of Eisaku Ogawa. A scholar is included among the top collaborators of Eisaku Ogawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eisaku Ogawa. Eisaku Ogawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Makino, Takamitsu, Hironobu Ihn, Motoo Nakagawa, et al.. (2020). Effect of adalimumab on axial manifestations in Japanese patients with psoriatic arthritis: a 24 week prospective, observational study. Lara D. Veeken. 60(8). 3669–3678. 2 indexed citations
2.
3.
Ogawa, Eisaku, Ryuhei Okuyama, Tomoko Seki, et al.. (2017). Epidemiological survey of patients with psoriasis in Matsumoto city, Nagano Prefecture, Japan. The Journal of Dermatology. 45(3). 314–317. 14 indexed citations
4.
Ogawa, Eisaku, et al.. (2017). In vasculitis of small muscular arteries, activation of vessel-infiltrating CD8 T cells seems to be antigen-independent. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 472(2). 271–279. 10 indexed citations
5.
Hidaka, Takanori, Eisaku Ogawa, Eri Kobayashi, et al.. (2016). The aryl hydrocarbon receptor AhR links atopic dermatitis and air pollution via induction of the neurotrophic factor artemin. Nature Immunology. 18(1). 64–73. 214 indexed citations
7.
Kiniwa, Yukiko, Eisaku Ogawa, Aya Uchiyama, et al.. (2014). Toll-Like Receptor 4 Signaling Promotes the Migration of Human Melanoma Cells. The Tohoku Journal of Experimental Medicine. 234(1). 57–65. 27 indexed citations
8.
Ogawa, Eisaku, et al.. (2014). Generalised Acanthosis Nigricans in Childhood with Short Stature Associated with Poor Response to Growth Hormone Provocation. Acta Dermato Venereologica. 94(4). 486–487. 1 indexed citations
9.
Ogawa, Eisaku, et al.. (2013). Current State of Therapies, Including with Biologics, for Psoriasis and the Prospects for Coordination on Treatment in Nagano Prefecture. The Nishinihon Journal of Dermatology. 75(4). 346–349. 1 indexed citations
10.
Uhara, Hisashi, Atsuko Ashida, Hiroshi Koga, et al.. (2013). NRAS mutations in primary and metastatic melanomas of Japanese patients. International Journal of Clinical Oncology. 19(3). 544–548. 26 indexed citations
11.
Ashida, Atsuko, et al.. (2012). A case of hypocomplementaemic urticarial vasculitis with a high serum level of rheumatoid factor. Australasian Journal of Dermatology. 54(3). e62–e63. 1 indexed citations
12.
Fujimura, Taku, Ryuhei Okuyama, Eisaku Ogawa, & Setsuya Aiba. (2009). Papuloerythroderma associated with monoclonal gammopathy of undetermined significance. The Journal of Dermatology. 36(4). 228–231. 3 indexed citations
13.
Okuyama, Ryuhei, Eisaku Ogawa, Kiyomi Kisu, et al.. (2009). Cutaneous accumulation of abnormal polyglutamine proteins of patients with dentatorubral‐pallidoluysian atrophy. European Journal of Neurology. 16(11). 1246–1249. 2 indexed citations
14.
Ogawa, Eisaku, Ryuhei Okuyama, Masuo Obinata, et al.. (2008). p63/p51-induced Onset of Keratinocyte Differentiation via the c-Jun N-terminal Kinase Pathway Is Counteracted by Keratinocyte Growth Factor. Journal of Biological Chemistry. 283(49). 34241–34249. 32 indexed citations
15.
Okuyama, Ryuhei, Eisaku Ogawa, Masato Yabuki, et al.. (2007). p53 homologue, p51/p63, maintains the immaturity of keratinocyte stem cells by inhibiting Notch1 activity. Oncogene. 26(31). 4478–4488. 61 indexed citations
16.
Ogawa, Eisaku, Ryuhei Okuyama, Shuntaro Ikawa, et al.. (2007). p51/p63 inhibits ultraviolet B-induced apoptosis via Akt activation. Oncogene. 27(6). 848–856. 19 indexed citations
17.
Kato, Shigekí, Yasuaki Mohri, Tsuyoshi Matsuo, et al.. (2007). Eye‐open at birth phenotype with reduced keratinocyte motility in LGR4 null mice. FEBS Letters. 581(24). 4685–4690. 45 indexed citations
18.
Ogawa, Eisaku, Yuji Owada, Noriko Kitanaka, et al.. (2006). Decreased keratinocyte motility in skin wound on mice lacking the epidermal fatty acid binding protein gene. Molecular and Cellular Biochemistry. 284(1-2). 183–188. 21 indexed citations
19.
Okuyama, Ryuhei, Claudio Talora, Eisaku Ogawa, et al.. (2004). High Commitment of Embryonic Keratinocytes to Terminal Differentiation through a Notch1-caspase 3 Regulatory Mechanism. Developmental Cell. 6(4). 551–562. 160 indexed citations
20.
Ogawa, Eisaku, et al.. (2003). Characteristic odour components of Citrus inflata Hort. ex Tanaka (Mochiyu) cold‐pressed peel oil. Flavour and Fragrance Journal. 18(5). 454–459. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026